🔎 Trials Near Me

Почетна › Рак (све врсте) › Mičigen › Grand Rapids

Kliničke studije za Рак (све врсте) u gradu Grand Rapids, MI

27 studija za Рак (све врсте) traži učesnike na lokacijama u gradu Grand Rapids i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study of YL242 in Subjects With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • US-206, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07197827

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Тражи се учесникФаза 3
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
  • Trinity Health Grand Rapids Hospital, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06580314

A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

Тражи се учесникФаза 1Здраве особе су добродошле
  • BAMF Health Inc., Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07258836

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

Тражи се учесникФаза 1
  • Start Midwest, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06150157

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Тражи се учесникФаза 3
  • The Cancer & Hematology Centers, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

A Study of JNJ-87890387 for Advanced Solid Tumors

Тражи се учесникФаза 1
  • Start Midwest, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06178614

A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)

Тражи се учесникФаза 2
  • START Midwest ( Site 1103), Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07209111

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Тражи се учесникФаза 1/2
  • Corewell Health ( Site 4001), Grand Rapids
1 Month – 17 Years · Оба пола · Ажурирано 30. 10. 2026. · NCT07630974

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Тражи се учесникФаза 1
  • START Midwest, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT07094204

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

Тражи се учесникФаза 1
  • START Midwest /ID# 279035, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT07409246

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

Тражи се учесникФаза 1
  • START Midwest, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06880549

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Тражи се учесникФаза 1/2
  • Corewell Health ( Site 3001), Grand Rapids
1 Month – 17 Years · Оба пола · Ажурирано 6. 10. 2026. · NCT06941272

REC-7735 in Participants With Solid Tumors

Тражи се учесникФаза 1/2
  • START Midwest, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT07819136

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Тражи се учесникФаза 3
  • Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 23. 9. 2026. · NCT07365241

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Тражи се учесникФаза 2
  • Cancer Research Consortium of West Michigan, Grand Rapids
Узраст 12 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT02693535

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Тражи се учесникФаза 1/2
  • START Midwest, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT06128551

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Тражи се учесникФаза 1
  • START - Midwest Cancer Research Center, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT06253871

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Тражи се учесникФаза 3
  • Cancer and Hematology Centers of Western Michigan, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT06252649

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

Тражи се учесникФаза 1
  • START Midwest, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 26. 8. 2026. · NCT07321106

Project: Every Child for Younger Patients With Cancer

Тражи се учесникОпсервациона студија
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
  • Trinity Health Grand Rapids Hospital, Grand Rapids
До 25 година · Оба пола · Ажурирано 25. 8. 2026. · NCT02402244

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

Тражи се учесникФаза 1/2
  • Site 04, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 19. 8. 2026. · NCT07276373

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

Тражи се учесникФаза 1
  • START Midwest, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 12. 8. 2026. · NCT06759649

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • START Midwest, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT05768139

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

Тражи се учесникФаза 1/2
  • START Midwest, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 1. 7. 2026. · NCT07079631

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

Тражи се учесникФаза 1
  • GSK Investigational Site, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 25. 6. 2026. · NCT06431594

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Тражи се учесникОпсервациона студија
  • Corewell Health, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 25. 6. 2025. · NCT05768269

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Тражи се учесник
  • Mercy Health Saint Mary's, Grand Rapids
  • Spectrum Health at Butterworth Campus, Grand Rapids
Узраст 18 и старији · Оба пола · Ажурирано 27. 11. 2024. · NCT03860883

Studije za Рак (све врсте) u drugim gradovima

Ostale studije u gradu Grand Rapids

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.